The 6 most recent market catalysts affecting $HKPD, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 17, 2026
Corporate Catalyst
Bullish
Impact 55
Cellyan Biotechnology Regains Compliance with Nasdaq Minimum Bid Price Requirement
Cellyan Biotechnology (HKPD) announced it has successfully regained compliance with Nasdaq's minimum bid price rule, a requirement for continued listing. The company had previously…
Oct 24, 2026
Corporate Catalyst
Neutral
Impact 65
Cellyan Biotechnology Announces 1-for-20 Reverse Stock Split
Cellyan Biotechnology (HKPD) has announced a 1-for-20 reverse stock split, meaning shareholders will receive one new share for every twenty old shares they own. This corporate acti…
Oct 21, 2026
Corporate Catalyst
Neutral
Impact 65
Cellyan Biotechnology Announces 1-For-20 Reverse Stock Split, Effective Oct. 26
Cellyan Biotechnology is implementing a 1-for-20 reverse stock split. This corporate action is typically undertaken by companies whose stock price has fallen significantly, often b…
Jul 17, 2026
Corporate Catalyst
Bearish
Impact 75
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened
Cellyan Biotechnology (HKPD) announced it received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price rule. This is a critical development as fai…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 75
HKPD stock has given up its prior gain. Cellyan Biotechnology shares were trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.
The headline indicates a significant corporate event for Cellyan Biotechnology (HKPD). The Nasdaq extension is a positive development as it prevents immediate delisting, but the su…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 55
Cellyan Biotechnology Granted 180‑Day Nasdaq Extension To Regain Compliance
Cellyan Biotechnology (HKPD) announced it received a 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, pushing the deadline to Januar…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.